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Abstract Stem cell heterogeneity is essential for the homeostasis in tissue
development. This paper established a general formulation for understanding the
dynamics of stem cell regeneration with cell heterogeneity and random transitions
of epigenetic states. The model generalizes the classical G0 cell cycle model, and
incorporates the epigenetic states of stem cells that are represented by a contin-
uous multidimensional variable and the kinetic rates of cell behaviors, including
proliferation, differentiation, and apoptosis, that are dependent on their epigenetic
states. Moreover, the random transition of epigenetic states is represented by an
inheritance probability that can be described as a conditional beta distribution.
This model can be extended to investigate gene mutation-induced tumor develop-
ment. The proposed formula is a generalized formula that helps us to understand
various dynamic processes of stem cell regeneration, including tissue development,
degeneration, and abnormal growth.
Keywords: Heterogeneity, stem cell, cell cycle, epigenetic state, development,
computational model
1 Introduction
Stem cell regeneration is an essential biological process in most self-renewing tis-
sues during development and the maintenance of tissue homeostasis. Stem cells
multiply by cell division, during which DNA is replicated and assigned to the two
daughter cells along with the inheritance of epigenetic information and the parti-
tion of molecules. Unlike the accumulated process of DNA replication, inherited
epigenetic information is often subjected to random perturbations; for example, the
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reconstruction of histone modifications and DNA methylation are intrinsically ran-
dom processes of writing and erasing the modified markers [71, 91]. The stochastic
inheritance of epigenetic changes during cell division can lead to stem cell hetero-
geneity which is important for the dynamic equilibrium of various phenotypic cells
during tissue development. Accumulation of undesirable epigenetic changes may
result in promoting or causing diseases [17, 18, 36, 43, 59, 60, 70, 72, 81, 92].
The heterogeneity of stem cells has been highlighted in recent years due to
new technologies with single-cell resolution, which have led to the discovery of
new cell types and changes in the understanding of differentiation landscapes [6,
9, 29, 50, 51, 69]. In early embryonic development, heterogeneous expression and
histone modifications are correlated with correlated with cell fate and the dynamic
equilibrium of pluripotent stem cells [33, 34, 68, 84]. Chromatin modifications in
the human primary hematopoietic stem cell/progenitor cell (HSC/HPC) stage
can lead to the dynamic equilibrium of heterogeneous and interconvertible HSCs
[10, 89], as well as gene expression changes during differentiations [11]. Moreover,
applications of single-cell RNA sequencing have revealed the continuous spectrum
of differentiation in zebrafish [54], mice [65], and human HSCs [85]. These findings
have challenged the demarcation between stem cells and progenitor cells and have
led to the evolving understanding of the complex hematopoietic differentiation
landscape [47, 66].
Heterogeneity plays an important role in the development of drug resistance.
Cancer development is driven by evolutionary selection on somatic genetic alter-
ations and epigenetic alterations, which result in the multistage tumorigenesis
and heterogenous cancer cell phenotypes [22, 23, 39, 51, 53, 64, 90]. Tumors
with different subtypes often differ in the treatment response and patient survival
[13, 23, 73], and treatment stress can also induce cancer cell plasticity and drug
resistance [24, 48, 57, 80, 82]. Cell plasticity is often associated with epigenetic
modifications, and targeting the epigenetic regulators, such as the polycomb group
protein EZH2, has been an attractive strategy in cancer treatment [20, 77, 83]. To
better understand the progress of tumorigenesis and drug resistance, we need to
develop predictive models of the evolutionary dynamics of cancer [3, 31].
Despite the central role of stem cell regeneration in tissue development, a quan-
titative investigation of the process is well beyond the ability of current technolo-
gies. Furthermore, in many fields of biological science, mathematical modeling
tools have aided in improving the understanding of the principles of related pro-
cesses [2, 45, 61, 62]. In 2007, Weinberg posed the following question [86]: can
algebraic formulae tell us more than reasoning about the behavior of complex bi-
ological systems? Various computational models have been established in studies
of tissue development and cancer systems biology under different circumstances
[3, 4, 16, 25, 26, 27, 87, 88]. Nevertheless, a unified formulation that bypasses
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detailed assumptions is required to provide more basic logic of the biological be-
haviors of these complex systems. In this study, based on the general process of
the cell cycle and heterogeneous stem cell regeneration, we established a general
mathematical framework to formulate the dynamics of heterogeneous stem cell
regeneration. The model framework includes essential cellular behaviors, includ-
ing proliferation, apoptosis and differentiation/senescence; however, it bypasses
the biological details of signaling pathways. The heterogeneity of stem cells and
epigenetic inheritance during the cell cycle are key points in model development.
Various formulas can be applied to different processes, such as embryonic devel-
opment, tissue disease and degeneration, and tumor development.
The aim of this paper was to introduce a new general formula for the dynamics
of stem cell regeneration with an emphasis on the effects of cell heterogeneity;
therefore, a discussion of concrete conclusions based on the formula was not in-
cluded. The simulation results below were included to demonstrate the potent
application of the model and were not related to any actual biological processes.
2 Results
2.1 The G0 cell cycle model for homogeneous stem cell
regeneration
A classical model that is used to describe the dynamics of stem cell regeneration
is the G0 cell cycle model proposed in the 1970s [7, 55]. In this model, homoge-
neous stem cell cycles are classified into resting (G0) or proliferating (G1, S, and
G2 phases and mitosis) phases (Figure 1A). During each cell cycle, a cell in the
proliferating phase either undergoes apoptosis or divides into two daughter cells;
however, a cell in the resting phase either irreversibly differentiates into a termi-
nally differentiated cell or returns to the proliferating phase. This can be modeled
by an age-structure model for cell numbers in the resting phase and proliferating
phase. Integrating the age-structure model through the characteristic line method
provides the following delay differential equation (Material and methods)
dQ
dt
= −(β(Q) + κ)Q+ 2e−µτβ(Qτ )Qτ . (1)
Here, β(Q) is the proliferation rate, µ is the apoptosis rate of cells in the prolif-
erating phase, τ is the duration of the proliferating phase, and κ is the rate of
removing cells out of the resting phase, which includes terminally differentiation,
cell death, and senescence (hereafter, we call κ the differentiation rate for simplic-
ity). Hereafter, the subscript indicates a time delay, i.e., Qτ indicates Q(t − τ).
The proliferation rate β(Q) describes how cells regulate the self-renewal of stem
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cells through secreted cytokines and is often given by a decrease function and
β0 < β(Q) < β∞ (Material and method). Typically, for normal individuals, we
usually have β∞ = limQ→+∞ β(Q) = 0 because of the inhibition of the cell cycle
pathway.
Figure 1: G0 cell cycle model for homogeneous stem cell regeneration.
(A). A schematic of the G0 model of stem cell regeneration. During stem cell
regeneration, cells in the resting phase either enter the proliferation phase with the
rate β or are removed from the resting pool with the rate κ due to differentiation,
aging, or death. Proliferating cells undergo apoptosis with the probability µ. (B).
Oncogenic signaling pathways and their associated cell behavior and parameters
in the G0 model. For each pathway, the genes are highly altered (according to
the dataset in the TCGA PanCancer Atlas) by oncogenic activation (red) and
tumor suppressor inactivators (blue). Details of the pathways and genes have
been described by [74].
The G0 cell cycle model and its extensions are widely used to investigate
hematopoietic stem cell dynamics [1, 19, 49, 56]; dysregulation of the apopto-
sis rate or differentiation rate of hematopoietic stem cells can result in serious
periodic hematopoietic diseases [12]. Moreover, from (1), the stem cell dynamics
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are mainly determined by pathways related to stem cell proliferation, apoptosis,
differentiation, senescence, and growth. Major oncogenic signaling pathways ob-
tained from an integrated analysis of genetic alterations in The Cancer Genome
Atlas (TCGA) [74] show direction connections to the coefficients β(Q), µ, and κ
in (1) (Figure 1B) (Material and methods). Equation (1) is capable of describing
the population dynamics of stem cell regeneration. Nevertheless, cell heterogene-
ity is not included in the model and has been highlighted in recent years for the
understanding of cancer development and drug resistance in cancer therapy.
2.2 The general framework of heterogeneous stem cell re-
generation
To extend the abovementioned G0 cell cycle model to include cell heterogeneity, we
introduce a quantity x (scalar or vector) for the epigenetic state of a cell and denote
Q(t,x) as the cell number at time t with state x (Figure 2A). In general, x can refer
to the expression levels of marker genes, histone modifications in nucleosomes, or
DNA methylations associated with DNA segments and can be measured by single-
cell sequencing techniques. Specifically, we often refer to x as quantities that affect
signaling pathways that control cell cycle progression, apoptosis, and cell growth,
so that the coefficients β, µ, and κ and the duration of the proliferating phase τ
in (1) are cell specific and dependent on the state x in the cell. Moreover, cells
in the niche can interfere with stem cell self-renewal through released cytokines.
Let ξ(x) denote the effective cytokine signal produced by a cell with state x, and
Qˆ =
∫
Q(t,x)ξ(x)dx denotes the total concentration of effective cytokines that
regulate cell proliferation. The proliferation rate in (1) becomes β(Qˆ,x).
While the cell-to-cell variability is considered, the inheritance of epigenetic
states of cells during cell division is essential to shape the distribution of cell het-
erogeneity. Many biological processes, such as the random partition of molecules
[38], random inheritance of nucleosome modification [14, 71] and DNA methyla-
tion [91, 36], can be involved in the affecting the inheritance of epigenetic states
from mother to daughter cells after cell division. Many efforts have been made to
model epigenetic cell memory [14, 30, 37, 38, 79]; however, it remains challenging
to develop precise models for this process that is not yet clear. Nevertheless, while
we overlook the biological details and focus on the changes of epigenetic states,
we introduce the inheritance probability p(x,y), which represents the probabil-
ity that a daughter cell of state x comes from a mother cell of state y after cell
division. Therefore, p(x,y)dx = 1 for any y. Based on the abovementioned as-
sumptions and the similar argument to the abovementioned homogeneous model,
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Figure 2: Heterogeneous stem cell regeneration. (A). A schematic of the
model of heterogeneous stem cell regeneration. Cell heterogeneity is represented
with by the epigenetic state (x) indicated by dots with different colors. The
dynamic rates for each cell are dependent on the epigenetic state, which varies
according to cell division with the inheritance probability p(x,y). (B). Simulated
population dynamics for the growth process with increasing of cell numbers to-
ward a steady state. (C). The simulated evolution of cell numbers with varying
heterogeneity in the growth process. The red arrows in (B) and (C) indicate a tem-
porary increase in cell subpopulation with a low level of x at the early stage. (D).
Simulated population dynamics of the degeneration process with the decreasing
cell numbers. (E). The percentage of cells with different epigenetic states during
the degeneration process. Timepoints for each curve are indicated by dots with
the same colors as those shown in (D). (F). Simulated population dynamics of the
abnormal growth process with the increasing of cell numbers. (G). The percent-
age of cells with different epigenetic states during the abnormal growth process.
Timepoints for each curve are indicated by triangles with the same colors as those
shown in (F). See Materials and methods for the simulation details.
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the dynamical equation for Q(t,x) is as follows (Material and methods):
∂Q(t,x)
∂t
= −Q(t,x)(β(Qˆ,x) + κ(x))
+ 2
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)p(x,y)dy
Qˆ(t) =
∫
Q(t,x)ξ(x)dx.
(2)
Here, the integrals are taken over all possible epigenetic states. Moreover, if we
consider discrete states, such as gene mutations, we can extend the integrals to
include the summation over all discrete states. Equation (2) extends the previous
G0 cell cycle model and provides a general framework for heterogeneous stem cell
regeneration.
Equation (2) is an autonomous system in which the rate functions and inher-
itance probability are not explicitly dependent on the time t. Nevertheless, while
we apply the equation to situations with time dependence, such as embryo devel-
opment, environmental changes, injury, and external stimuli, the time-dependent
rate functions and the inheritance probability can be included in a straightforward
manner. An example is shown in Figure 5 below.
Based on the (2), while we introduce appropriate definitions for the dependence
of kinetic rates on epigenetic states and the inheritance function, we are able to
model various processes of stem cell regeneration, such as tissue growth, degen-
eration, and abnormal growth (Figures 2B-G). For simplicity, in all simulations
shown in this paper, we consider one epigenetic state x (0 ≤ x ≤ 1) that affects
only cell proliferation and differentiation in a manner similar to the stemness so
that a larger value of x indicates higher stemness (Material and methods). Fig-
ure 2B-C shows the dynamics of tissue growth starting from a small population
cells with high levels of stemness toward a steady state. There is a temporary
transition at the early stage characterized by a rapid increase in the cell number
and a subpopulation of cells with low level stemness (Figures 2B-C, red arrows).
Figures 2D-E shows the dynamics of degeneration with alterations to the inheri-
tance function, and Figures 2F-G shows the abnormal growth due to a decreasing
differentiation rate and an alteration to the inheritance function. Both processes
include a short-term stage of biphenotypic cell populations with both high and low
stemness cells (Figure 2E and G, red curve). Moreover, the simulations show that
the steady state heterogeneity can be restored from cell subpopulation fractions
(Figure 3), which is in agreement with experiments that were previously explained
by transcriptome-wide noise [35, 52, 89].
Equation (2) describes the evolution of the cell numbers with various epigenetic
states; however, the total cell number Q(t) =
∫
Q(t,x)dx and the density of cells
with different epigenetic states f(t,x) = Q(t,x)/Q(t) are relevant to the data.
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Figure 3: Restoration of heterogeneity from cell subpopulation fractions.
Clonal cells with the highest (x > 0.75), middle (0.55 < x < 0.65), and lowest
(x < 0.45) epigenetic states independently re-established the parental extent of
clonal heterogeneity in separate simulations.
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From equation (2), it is easy to obtain the equations for Q(t) and f(t,x) as follows
(see Materials and methods):
dQ
dt
= −
∫
Q(t,x)(β(Qˆ,x) + κ(x))dx (3)
+ 2
∫
β(Qˆτ(x),x)Q(t− τ(x),x)e−µ(x)τ(x)dx,
and
∂f(t,x)
∂t
= −f(t,x)
∫
f(t,y)((β(Qˆ,x) + κ(x))− (β(Qˆ,y) + κ(y)))dy (4)
+
2
Q(t)
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)(p(x,y)− f(t,x))dy.
Equations (3) and (4) provide the evolution dynamics of relative cell numbers that
can be obtained from experiments by single-cell sequencing or flow cytometry.
Here we note that when ξ(x) = 1, we have Qˆ(t) = Q(t), and hence, (3)-(4) provide
a closed-form equation.
Here, the state variable x represents the epigenetic state, and p(x,y) represents
the inheritance function; hence, (2) describes the dynamics with epigenetic state
transitions. Nevertheless, this equation can also describe the changes in genetic
alternations if we consider x as the genetic state and p(x,y) as the probability
of point mutations. This is often the situation of genomic instability associated
with cancer development [8, 32, 78, 93], and hence, the model can be used to
study genetic heterogeneity in cancer development. In this paper, we focus on the
equation with epigenetic state transitions and assumed that x always represents
the epigenetic state.
2.3 Stochastic epigenetic state inheritance in the cell cycle
In Equations (2)-(4), the mathematical formula of epigenetic state-relevant coef-
ficients should be expressed based on how the epigenetic states (or genes) affect
the relative biological process. However, the inheritance function p(x,y) cannot
be determined from the biological process of cell division. Here, we derive a phe-
nomenological inheritance function to represent the stochastic inheritance of the
epigenetic states. More specifically, let x = (x1, x2, · · · , xn) represent the expres-
sion level of n marker genes, and derive the inheritance function pi(xi,y) for each
gene, and p(x,y) =
∏n
i=1 pi(xi,y).
We assume that the epigenetic state of a daughter cell is a random number with
the distribution depending on that of the mother cell. In previous studies based
on stochastic simulations of gene expression coupled with nucleosome modifica-
tions over multiple cell cycles [37, 40], we found that the nucleosome modification
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level of daughter cells, considering the nucleosome modification level of mother
cells, which is normalized to the interval [0,1], can be well-described by a beta-
distributed random number. Therefore, we generalized these findings and defined
the inheritance function pi(xi,y) through the beta distribution density function as
follows:
pi(xi,y) =
x
ai(y)
i (1− xi)bi(y)
B(ai(y), bi(y))
, B(a, b) =
Γ(a)Γ(b)
Γ(a+ b)
, (5)
where Γ(z) is the gamma function and a and b are shape parameters depending
on the state of the mother cell. We assumed that the mean and variance of xi,
considering y, is as follows:
E(xi|y) = φi(y), Var(xi|y) = 1
1 + ηi(y)
φi(y)(1− φi(y)),
and the shape parameters are (Materials and methods)
ai(y) = ηi(y)φi(y), bi(y) = ηi(y)(1− φi(y)). (6)
Here, we note that φi(y) and ηi(y) always satisfy
0 < φi(y) < 1, ηi(y) > 0. (7)
Hence, the inheritance function can be determined through the predefined func-
tions φi(y) and ηi(y), often through data-driven modeling or assumptions, that
satisfies (7).
2.4 Modeling tumor development with cell-to-cell variance
As shown in Figure 2F-G, to mimic the process of abnormal cell growth, we varied
the differentiation rate and the inheritance probability. These variances to the
model parameters can be a consequence of changes in the microenvironment that
may affect all stem cells in the niche. Nevertheless, to model tumor development
considering driver gene mutations to individual cells, we need to modify the model
equations to include the mutants.
To show the framework for modeling tumor development induced by driver
gene mutations, we consider the process with two types of mutations that increase
the proliferation rate and decrease the differentiation rate (Figure 4A). Hence,
let Qi(t,x) (i = 0, 1, 2, 3) represent the wild-type (i = 0) and the three mutant
subpopulations (i = 1, 2, 3) cell counts, and pi,j represents the mutation rates.
For the simplicity, we assume that gene mutations occur during cell division, and
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two daughter cells have the same mutant type. Therefore, equation (2) can be
extended as follows:
∂Qi(t,x)
∂t
= −Qi(t,x)(βi(Qˆ,x) + κi(x))
+ 2(1−
∑
j 6=i
pi,j)
∫
βi(Qˆτ(y),y)Qi(t− τ(y),y)e−µ(y)τ(y)p(x,y)dy
+ 2
∑
j 6=i
pj,i
∫
βj(Qˆτ(y),y)Qj(t− τ(y),y)e−µ(y)τ(y)p(x,y)dy,
and
Qˆ(t) =
3∑
i=0
∫
Qi(t,x)ξ(x)dx.
Here, we consider only the driver mutation types, and at most one mutation occurs
in each cell cycle, so that only the mutation rates p0,1, p0,2 and p1,3, p2,3 are nonzero
value; and otherwise, the mutation rate pi,j is zero (Figure 4A).
Figure 4: Simulated tumor development driven by mutations in prolifer-
ation and differentiation pathways. (A). Cell types and mutation probability
pi,j. Mutant 1 represents the cell type with an increased proliferation rate, mu-
tant 2 represents the cell type with a decreasing differentiation rate, and mutant
3 represents the cell type with a double mutation. (B). Evolution dynamics of
total cell numbers (upper panel), mutant cells Q1(t) and Q2(t) (middle panel), and
fractions of wild-type and mutant cells (lower panel). (C). The evolution of cell
density during tumor development.
Figure 4B-C shows the simulated dynamics. Single mutant cells occur prior to
the obvious increase in the cell number, and the mutant cells eventually develop
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to double mutations that dominate the cell population (Figure 4B). Moreover,
our simulation suggests that stemness increases with evolutionary processes when
we limit the mutations to proliferation and differentiation (Figure 4C). Here, we
consider only two types mutations that often occur in the precancerous stage
[15, 27]. To simulate a more complicated process of cancer development, we must
extend the simulation to include more mutations, such as apoptosis, DNA damage
repair, and immune response pathways.
2.5 Modeling tissue growth with cell lineage dynamics
In the abovementioned models, we considered only cells capable of self-renewal,
e.g., stem cells and progenitor cells. Nevertheless, to model tissue growth, we must
include terminal differentiated cells that lose the ability to progress through the cell
cycle. Therefore, let Q(t,x) represent cells with self-renewal ability as previously
mentioned, and let P (t,x) represent the number of terminally differentiated cells.
The terminally differentiated cells are produced from the stem and progenitor
cells with the rate κ(x) and cleared with the rate ν(x). Hence, equation 2 can be
reformulated as follows:
∂Q(t,x)
∂t
= −Q(t,x)(β(Qˆ,x) + κ(x))
+ 2
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)p(x,y)dy
∂P (t,x)
∂t
= κ(x)Q(t,x)− ν(x)P (t,x).
(8)
In the simulations shown in Figure 2, by considering the epigenetic state 0 ≤ x ≤ 1
as a stemness index and by distinguishing the stem cells from progenitor cells with
the boundary x = x0 (Figure S1), the numbers of stem cells, progenitor cells, and
terminally differentiated cells can be determined as follows:
Qstem(t) =
∫ 1
x0
Q(t, x)dx, Qprogenitor(t) =
∫ x0
0
Q(t, x)dx, P (t) =
∫ 1
0
P (t, x)dx.
This equation provides a model of multistage cell lineages shown in previous
studies [1, 21, 46]. The tissue size is given by the total cell number as follows:
S(t) = Qstem(t) +Qprogenitor(t) + P (t),
and the distribution of stemness among all tissue cells is given by
f(t, x) =
Q(t, x) + P (t, x)
S(t)
.
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Figure 5 shows the simulated dynamics beginning with 100 stem cells, which re-
veal the transition between stem and progenitor cells and the differentiation to
terminally differentiated cells. Figure 5B shows the density of phenotypically dif-
ferent cell populations among the stem cells, progenitor cells and the terminally
differentiated cells.
Figure 5: The dynamics of tissue growth. (A). Simulated dynamics of tissue
growth beginning with 100 stem cells at day 0. Upper panel: total cell number.
Lower panel: fractions of stem cells, progenitor cells, and terminally differentiated
cells. (B). Density of the epigenetic state of three cell populations at day 35 (gray
dashed line shown in (A)). Here, SP cells indicate stem and progenitor cells, and
TD cells indicate terminally differentiated cells. The stem cells were defined as
0.7 ≤ x ≤ 1, and progenitor cells were defined as 0 < x < 0.7. See the Material
and methods for the simulation details.
3 Discussion
Stem cell and progenitor cell regeneration is a basic cellular behavior associated
with development, aging, and many complex diseases in multicellular organisms.
In this study, to overlook the genetic details, we established a general mathemat-
ical framework to describe the process of stem cell and progenitor cell regenera-
tion. This framework highlights cell heterogeneity and connects heterogeneity with
cellular behaviors, e.g., proliferation, apoptosis, and differentiation/senescence.
Cell heterogeneity is often associated with epigenomic markers that are subject
to stochastic inheritance during cell division and is described by an inheritance
probability function. Hence, the framework is a multiscale model that incorpo-
rates microscopic epigenetic state and gene expressions with macroscopic tissue
growth through mesoscopic cell behaviors. We believe that this formula is helpful
in answering the Weinberg question [86]. Despite the generality of this formula,
different assumptions regarding the kinetic rate function and the inheritance prob-
ability can be applied to describe various biological processes related to stem cell
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regeneration (Figure 2).
In our framework, all stem and progenitor cells are described with a single
compartment model, and different phenotypic cells are not distinguished explic-
itly. This approach differs from differentiation tree models that are widely used to
describe the maintenance of hierarchically organized tissues. Recent experimental
results have challenged the discrimination between stem and progenitor cell pop-
ulations and have shown a continuous spectrum of results from cell differentiation
[47, 65, 85]. Stochastic state transitions between different phenotypic cells lead to
a dynamic equilibrium among a population of self-renewing cells [28, 52, 75]. Our
model suggested that discrimination between cell types may not be necessary to
describe tissue homeostasis. Different subtypes of cells can be characterized by
their kinetic rates of proliferation, apoptosis, differentiation, senescence, etc. For
convenience, these dynamic features are referred to as the kinotype, which is anal-
ogous to the genotype, epigenotype, and phenotype of a cell. The kinotype of cells
is often associated with specific genes enriched in the related pathways. If the rela-
tionship between kinetic rates and the expression of these genes are known, we can
extend the proposed framework to include the roles of specific genes. Therefore,
in the future, we aim to develop a predictable model to investigate how variations
in specific genes serve to alter the long-term dynamics of tissue growth.
Figure 6: A schematic of the computational scheme for stem cell regen-
eration.
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Although the probabilistic epigenetic inheritance was considered, equation (2)
is a deterministic equation that describes the dynamics of cell densities with differ-
ent epigenetic states. This model often provides information regarding the average
of multiple cells. To model a single cell, we must perform stochastic simulations
that explicitly account for random events. Equation (2) suggests a numerical
scheme of multiscale modeling for tissue growth where a multiple cell system is
represented by a collection of epigenetic states in each cell as Ωt =
{
[Ci(xi)]
Q(t)
i=1
}
.
In each cell cycle, each cell undergoes proliferation, apoptosis, or terminal differen-
tiation with a probability following the given kinetic rate so that both the system
state Ωt and the cell count Q(t) change, and the epigenetic state of each cell un-
dergoing cell division changes according to the predefined inheritance probability
p(x,y). In our previous study, this computational model was applied to model the
process of inflammation-induced tumorigenesis and reproduced the two-stage tu-
morigenesis dynamics and revealed the competing oncogenic and onco-protective
roles of inflammation. Based on the simulation results, which include the evolu-
tion of single-cell states, we were able to uncover the detailed process of cancer
development.
Material and methods
Resource
Source MATLAB code for the study is available from
https://github.com/jzlei/StemCell.
Age-structured model and delay differential equation mod-
els
In the G0 cell cycle model, Q(t) is the number of resting-phase stem cells, s(t, a) is
an age-structured quantify to represent the population of proliferating stem cells,
and the age a = 0 is their time of entry into the proliferative state. The resting-
phase cells can either reenter the proliferative phase at a rate β(Q) or differentiate
into downstream cell lines at a rate κ. The proliferating stem cells are assumed to
undergo mitosis at a fixed time τ after entry into the proliferating compartment
and to be lost randomly at a rate µ during the proliferating phase. Each normal
cell generates two resting-phase cells at the end of mitosis. Here, the units of cell
population are often measured by the number of cells per unit body weight, e.g.,
cells/kg, and the rates of proliferation, differentiation, and apoptosis are often
united with day−1.
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The above assumptions yield the following partial differential equations [49]:
∇s(t, a) = −µs(t, a), (t > 0, 0 < a < τ)
dQ
dt
= 2s(t, τ)− (β(Q) + κ)Q, (t > 0) (9)
Here, ∇ = ∂/∂t+ ∂/∂a. The boundary condition at a = 0 is as follows:
s(t, 0) = β(Q(t))Q(t), (10)
and the initial conditions are
s(0, a) = g(a), (0 ≤ a ≤ τ); Q(0) = Q0. (11)
Equations (9)-(11) provide a general age-structured model of homogeneous stem
cell regeneration.
By integrating (9)-(10) with the characteristic line method, we obtain the fol-
lowing close-form differential equation [49]:
dQ
dt
= −(β(Q) + κ)Q+
{
2g(τ − t)e−µt, 0 < t ≤ τ
2e−µτβ(Qτ )Qτ , t > τ
(12)
where Qτ = Q(t− τ). When we consider only the long-term behavior (t > τ) and
shift the original time point to τ , the delay differential equation model is as follows
dQ
dt
= −(β(Q) + κ)Q+ 2e−µτβ(Qτ )Qτ . (13)
This equation describes the general population dynamics of homogeneous stem cell
regeneration.
Formulation of the proliferation rate
The effect of feedback regulation from the cell population to the proliferation rate
is given by the function β(Q). Biologically, the self-renewal ability of a cell is de-
termined by both microenvironmental conditions, e.g., growth factors and various
types of cytokines, and intracellular signaling pathways, e.g., growth factor recep-
tors and cell cycle checkpoints, such as fibroblast growth factors (FGFs) and the
transforming growth factor beta (TGF-β) family [58, 63, 67]. The exact activation
pathways that regulate the self-renewal of stem cells are poorly understood. Here,
we derived a phenomenological formulation based on simple but general assump-
tions.
There are positive and negative signals for stem cell proliferation. We assume
that positive growth factors are secreted by the niche, and growth factor inhibitors
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are released by the cells. Different types of cytokines bind to the cell surface
receptors to regulate cell behavior. Let [L] denote the concentration of ligands
for growth factor inhibitor; [R], the density of free receptor; [R∗ ], the density of
activated receptor; Q, the stem cell number. The total number of receptors is
[R] + [R∗] = mQ,
where m is the average number of receptors per cell. If n ligands are required to
activate one receptor, we assume that ligands bind to the receptor following the
law of mass action as follows:
[R] + n[L] [R∗].
At equilibrium, we have the following equation:
[R][L]n = K[R∗] (14)
where K is the equilibrium constant. We assume that the activated receptors
inhibit cell proliferation so that the proliferation rate is proportional to the fraction
of free receptors on a cell as follows:
β = β0
[R]
mQ
. (15)
From (14)-(15), we obtain the following expression:
[R]
mQ
=
1
1 + [L]n
.
When ligands are secreted from stem cells and are cleared at a constant rate,
the ligand concentration is proportional to the cell number, which gives [L] = σQ.
Thus, we obtain the final form of the proliferation rate as follows:
β(Q) = β0
θn
θn +Qn
, (16)
where θ = (1/σ)1/n is the 50% effective coefficient (EC50).
From (16), the proliferation rate, which is important for tissue homeostasis,
approaches 0 due to the antiproliferation signals when the cell number Q is suf-
ficiently large. However, the capabilities of self-sufficiency in growth signals and
insensitivity to antigrowth signals are the two characteristics of cancer that enable
malignant tumor cells to escape antigrowth signals [31]. Hence, to model tumor
development, the proliferation rate can be modified to include a nonzero constant
β1 for self-sustained growth signals as follow:
β(Q) = β0
θn
θn +Qn
+ β1. (17)
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Steady state of the G0 cell cycle model and oncogenic sig-
naling pathways
From (13), the steady state Q(t) ≡ Q∗ is given by the equation
−(β(Q∗) + κ)Q∗ + 2e−µτβ(Q∗)Q∗ = 0,
which yields either Q∗ = 0, or
β(Q∗) =
κ
2e−µτ − 1 . (18)
When β(Q) is given by (17), equation (13) has a unique positive steady state if
and only if
β0 >
κ
2e−µτ − 1 − β1 > 0.
In particular, when
β1 ≥ κ
2e−µτ − 1 , (19)
(13) has only a zero steady state, and the zero solution is unstable. Hence, all
positive solutions approach infinity, which corresponds to uncontrolled growth.
Therefore, the inequality (19) summarizes a general condition to have uncon-
trolled growth, i.e., malignant tumors. Biologically, equation (19) is satisfied if
there is self-sufficiency in growth signals and/or insensitivity to antigrowth sig-
nals (increasing β1), evasion of apoptosis (decreasing µ), and dysregulation in the
differentiation and/or senescence pathways (decreasing κ), which are well known
hallmarks of cancer [31].
Age-structured model of heterogeneous stem cell regenera-
tion
When heterogeneity in stem cells is considered, and assumed that the apoptosis
rates of cells during cell division are dependent on the epigenetic state of the cell
before entering the proliferating phase, the age-structured model (9) becomes
∇s(t, a,x) = −µ(x)s(t, a,x), (t > 0, 0 < a < τ(x))
∂Q(t,x)
∂t
= 2
∫
s(t, τ(y),y)p(x,y)dy − (β(Qˆ(t),x) + κ(x))Q(t,x), (t > 0)
and
s(t, 0,x) = β(Qˆ(t),x)Q(t,x).
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While we considered the epigenetic state x in the first equation as a parameter,
the characteristic line method remains valid, which gives the following equation
(here we show only the result of long-term behavior):
s(t, τ(x),x) = β(Qˆ(t− τ(x),x),x)Q(t− τ(x),x)e−µ(x)τ(x).
Substituting s(t, τ(x),x) into the second equation, we obtained the following equa-
tion:
∂Q(t,x)
∂t
= −Q(t,x)(β(Qˆ,x) + κ(x)) (20)
+ 2
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y))p(x,y)dy,
which gives the equation (2) for heterogeneous stem cell regeneration.
Let
Q(t) =
∫
Q(t,x)dx,
which is the total cell number, and integrate (20) with x. Notably, when p(x,y)dx =
1, we obtain the following equation:
dQ
dt
= −
∫
Q(t,x)(β(Qˆ,x) + κ(x))dx + 2
∫
β(Qˆτ(x),x)Q(t− τ(x),x)e−µ(x)τ(x)dx.
Define
f(t,x) =
Q(t,x)
Q(t)
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as the density of cells with a given epigenetic state x, then
∂f(t,x)
∂t
=
1
Q(t)
∂Q(t,x)
∂t
− Q(t,x)
Q(t)2
dQ(t)
dt
= −f(t,x)(β(Qˆ,x) + κ(x))
+
2
Q(t)
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)p(x,y)dy
− f(t,x)
Q(t)
(
−
∫
Q(t,x)(β(Qˆ,x) + κ(x))dx
+ 2
∫
β(Qˆτ(x),x)Q(t− τ(x),x)e−µ(x)τ(x)dx
)
= −f(t,x)
∫
f(t,y)(β(Qˆ,x) + κ(x))dy
+ f(t,x)
∫
f(t,y)(β(Qˆ,y) + κ(y))dy
+
2
Q(t)
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)p(x,y)dy
− 2
Q(t)
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)f(t,x)dy
= −f(t,x)
∫
f(t,y)
(
(β(Qˆ,x) + κ(x))− (β(Qˆ,y) + κ(y))
)
dy
+
2
Q(t)
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)(p(x,y)− f(t,x))dy.
Hence, we obtained the equation
∂f(t,x)
∂t
= −f(t,x)
∫
f(t,y)
(
(β(Qˆ,x) + κ(x))− (β(Qˆ,y) + κ(y))
)
dy (21)
+
2
Q(t)
∫
β(Qˆτ(y),y)Q(t− τ(y),y)e−µ(y)τ(y)(p(x,y)− f(t,x))dy.
The inheritance probability p(x,y)
In (2), the inheritance probability p(x,y) is essential to describe the heterogeneity
of cells. The function p(x,y) is associated with the process of cell division dur-
ing which the epigenetic code and molecules distribute to daughter cells through
complex regulation mechanisms that are not well understood. Hence, the gen-
eral mathematical formula of the function p(x,y) remains unknown. Here, we
proposed an attempt to define the function based on the random inheritance of
histone modifications.
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In eukaryotic cells, most DNA sequences are enclosed in nucleosomes in which
DNA sequences wrap around a histone octamer that is composed of one (H3-H4)2
tetramer capped by two H2A-H2B dimers. These histones can undergo diverse
posttranslational covalent modifications that lead to either active or repressive
gene expression activities [5, 41, 44]. The patterns of histone modification dy-
namically change over time, and hence define a dynamic histone code for the
transcription activity. The dynamics of histone modifications consist of complex
process, including nucleosome assembly, writing and erasing of the modification
markers, and random inheritance during DNA replication [71, 76]. Detailed com-
putational models for the process of histone modification and random inheritance
over the cell cycle remain a challenging issue in computational biology. While we
consider the main process of writing and erasing the modification markers that
are modulated by the related enzymes, the kinetics of histone modification can be
modeled through stochastic simulations [37, 42].
In a proposed dynamic model of histone modification [37, 42], bivalent modi-
fications of the histone H3, the trimethylation of H3 lysine 4 (H3K4me3) and the
trimethylation of H3 lysine 27 (H3K27me3), were considered. Each H3 histone
can be in one of the following states: unmodified (U), modified by the activat-
ing marker H3K4me3 (A), or modified by the repressing marker H3K27me3 (R).
Each nucleosome can be in one of six physically nucleosome states, which include
UU, AU, UR, AA, AR, and RR. The nucleosome states dynamically change ac-
cording to methylation/demethylation, which are regulated by corresponding en-
zymes. During DNA replication, parental histones and newly synthesized histones
are randomly distributed on daughter strands. To avoid the dilution of histone
markers, maintenance modifications in the new histones can be achieved by using
a neighboring histone as a template [71]. Hence, writing enzyme activities are
dependent on the states of neighboring nucleosomes. Thus, changes in the nucle-
osome state over the cell cycle due to the random distribution of histone markers
during DNA replication and kinetic methylation/demethylation can be tracked
with a stochastic simulation [37].
Based on the abovementioned model simulation, we are able to study how
the nucleosome state of daughter cells depends on that of the mother cells. For
example, considering a DNA segment with N nucleosomes, we counted the number
(NA) of nucleosomes with active markers (either AA or AU) at each cycle. The
simulation results suggested that considering the state of the mother cell, the
active nucleosome number is a random number with a binomial distribution with
the parameter (success probability p) dependent on the state of the mother cell as
follows [37]:
P (NA,k+1 = n|NA,k = m) = CnNpn(1− p)N−n, where p = p(m).
Considering the nucleosome state through the fraction (fA = NA/N) of active
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nucleosome numbers, we can extend the binomial distribution to a continuous
probability distribution defined on the interval [0, 1], which is given by the following
beta distribution:
P (fA,k+1 = x|fA,k = y) = x
a(y)(1− x)b(y)
B(a(y), b(y))
.
Hence, for the specific situation of the random inheritance of histone modifications
during the cell cycle, we can use the beta distribution probability as the inheritance
probability function p(x, y). Here, we extend this formulation to general cases and
proposed (5) for the inheritance functions.
Beta distribution
The beta distribution is a family of continuous probability distributions defined
on the interval [0, 1] and is parameterized by two positive shape parameters that
appear as exponents of the random variable and that control the shape of the
distribution. The probability density function (PDF) of the beta distribution, for
0 ≤ x ≤ 1, and the shape parameters a, b > 0, is a power function of the variable
x and of its reflection (1− x) as follows:
f(x; a, b) =
xa(1− x)b
B(a, b)
, B(a, b) =
Γ(a)Γ(b)
Γ(a+ b)
,
where Γ(z) is the gamma function.
For a random variable X beta-distributed with parameters a and b, which is
denoted by X ∼ beta(a, b), the mean and variance are as follows:
E[X] =
a
a+ b
, Var[X] =
ab
(a+ b)2(a+ b+ 1)
.
Then, it is easy to obtain
Var[X] =
1
1 + a+ b
E[X](1− E[X]).
Hence, if we assume
E[X] = φ, Var[X] =
1
1 + η
φ(1− φ),
then
φ =
a
η
, η = a+ b,
which gives
a = ηφ, b = η(1− φ).
This gives equation (6) to determine the shape parameters from the functions φi(y)
and ηi(y).
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Simulations for stem cell regeneration
Here, we present a simple example to show the numerical scheme to simulate stem
cell regeneration based on the proposed model equations.
We consider a situation with one epigenetic state x (0 ≤ x ≤ 1) that affects only
cell proliferation and differentiation so that only the rates β and κ are dependent
on the epigenetic state x. Therefore, we have the following model equation:
∂Q(t, x)
∂t
= −Q(t, x)(β(Qˆ(t), x)+κ(x))+2e−µτ
∫ 1
0
β(Qˆ(t−τ), y)Q(t−τ, y)p(x, y)dy.
Here, ξ(x) = 1 so that
Qˆ(t) =
∫ 1
0
Q(t, x)dx.
To specify the rate functions β and κ, we assume that the state x affects
the proliferation and differentiation rates in a manner similar to the stemness so
that large value of x indicates the stem cells with a low proliferation rate, an
intermediate value x indicates progenitor cells with a high proliferation rate, and
the terminated differentiation rate κ is a decreasing function of x that approaches
zero when x is large. This is mathematically expressed as follows:
β(Qˆ, x) = β0(x)
θ
θ + Qˆ
, β0(x) = β¯ × a1x+ (a2x)
2
1 + (a3x)6
,
and
κ(x) = κ0 × 1
1 + (b1x)6
.
The inheritance probability function p(x, y) is defined from the beta distribu-
tion density function as with predefined function φ(y) and η(y) as follows:
p(x, y) =
xa(y)(1− x)b(y)
B(a(y), b(y))
, B(a, b) =
Γ(a)Γ(b)
Γ(a+ b)
and
a(y) = η(y)φ(y), b(y) = η(y)(1− φ(y)).
Figure 7 shows the functions β0(x), κ(x), and p(x, y).
In the simulations shown in Figure 2, the parameters are as follows: µ = 2.0×
10−4 h−1, τ = 20 h, θ = 103cells, a1 = 5.8, a2 = 2.2, a3 = 3.75, b1 = 4.0, η(x) = 60,
and
• in (B)-(C): β¯ = 0.12 h−1, κ0 = 0.02 h−1, φ(x) = 0.08 + 1.0× (1.65x)1.81+(1.65x)1.8 ;
• in (D)-(E): β¯ = 0.12 h−1, κ0 = 0.02 h−1, φ(x) = 0.04 + 0.9× (1.65x)1.81+(1.65x)1.8 ;
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Figure 7: Example of the rate functions. (A). The proliferation rate β0(x)
and the differentiation rate κ(x). (B). The inheritance probability p(x, y). Here,
the parameters are a1 = 5.8, a2 = 2.2, a3 = 3.75, b1 = 4.0, and φ(x) = 0.08 + 1.0×
(1.65x)1.8
1+(1.65x)1.8
, η(x) = 60.
• in (F)-(G): β¯ = 0.12 h−1, κ0 = 0.0002 h−1, φ(x) = 0.08 + 1.2× (1.65x)1.81+(1.65x)1.8 .
In the simulation show in Figure 3, β¯ = 4.8h−1, κ0 = 0.4h−1, and other param-
eters are the same as those shown in Figure 2B.
In the simulation shown in Figure 4, we set the wild-type cell parameters
according to those shown in Figure 2B, and p0,1 = p0,2 = 0.5× 10−4, p1,3 = p2,3 =
1× 10−4. For mutation 1, the proliferation rate is twice of wild-type cells, and for
mutation 2, the differentiation rate is 1/10 of wild-type cells.
In the simulation shown in Figure 5, we set x0 = 0.7, the differentiation rate
increases from 0 to normal level following κ(t) = 0.04 × (1
2
− 1
1+et/10000
), and the
other parameters are the same as those shown in Figure 2B.
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